AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 99 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.89 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $521,000 | -64.4% | 11,300 | -57.5% | 0.00% | -60.0% |
| Q2 2021 | $1,465,000 | +100.1% | 26,600 | +27.1% | 0.01% | +66.7% |
| Q3 2020 | $732,000 | +308.9% | 20,931 | +883.1% | 0.00% | +200.0% |
| Q2 2018 | $179,000 | -81.4% | 2,129 | -79.1% | 0.00% | -75.0% |
| Q1 2015 | $961,000 | -18.3% | 10,200 | -2.9% | 0.00% | -20.0% |
| Q4 2014 | $1,176,000 | -29.5% | 10,500 | -61.4% | 0.01% | +25.0% |
| Q3 2014 | $1,668,000 | – | 27,200 | – | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2013 | $67,000 | -23.0% | 2,800 | -9.7% | 0.00% | – |
| Q3 2013 | $87,000 | – | 3,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |